Andre beskyttede aminosyrer for disulfidbinding
Produktdetaljer
| NO | Produkter | Cas nei | Søknad | Nøkkelkvalitetsindikator | ||||
| Renhet | Isomer | Spesifikk urenhet | *MAX1 | Fuktighet | ||||
| 1 | Fmoc-cys (ACM) -OH | 86060-81-3 | Disulfidbinding | ≥99,0% | ≤0,1% | ≤0,1% | ≤0,2% | ≤ 1,0% |
| 2 | FMOC-CYS (MMT) -OH | 177582-21-7 | Disulfidbinding | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤ 1,0% |
| 3 | FMOC-CYS (4-Allylbutyrate) -OH | / | Disulfidbinding | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤ 1,0% |
| 4 | MPA (TRT) -OH | 27144-18-9 | Slutten av sekvensen | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤ 1,0% |
| 5 | Fmoc-thr (tbu) -ol | 189337-28-8 | Oktreotid | ≥97,0% | ≤0,3% | ≤0,5% | ≤ 1,0% | ≤ 1,0% |
| 6 | FMOC-D-ARG (PBF) -OH | 187618-60-6 | Desmopressin | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤2,0% |
| 7 | Fmoc-Gly-Gly-Oh | 35665-38-4 | Bivalirudin | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤ 1,0% |
| 8 | Fmoc-Gly-Gly-Gly-Oh | 170941-79-4 | Terlipressin | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤ 1,0% |
| 9 | Fmoc-Gly-Gly-Gly-Gly-Oh | / | Bivalirudin | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤ 1,0% |
| 10 | Fmoc-Gly-ASP (TBU) -OH | / | Bivalirudin | ≥99,5% | / | ≤0,15% | ≤0,2% | ≤ 1,0% |
| 11 | BOC-CYS (TRT) -OH | 21947-98-8 | Slutten av sekvensen | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤ 1,0% |
| 12 | BOC-ARG (PBF) -OH | 200124-22-7 | Slutten av sekvensen | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤ 1,0% |
| 13 | Boc-Ala-Oh | 15761-38-3 | Slutten av sekvensen | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤ 1,0% |
| 14 | BOC-D-Phe-Oh | 18942-49-9 | Slutten av sekvensen | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤ 1,0% |
| 15 | Boc-Gly-Oh | 4530-20-5 | Slutten av sekvensen | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤ 1,0% |
| 16 | BOC-LYS (BOC) -OH.DCHA | 15098-69-8 | Slutten av sekvensen | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤ 1,0% |
| 17 | BOC-SER (TBU) -OH | 7738-22-9 | Slutten av sekvensen | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤ 1,0% |
| 18 | Boc-thr (tbu) -oh | 13734-40-2 | Slutten av sekvensen | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤ 1,0% |
| 19 | BOC-D-Ala-oh | 7764-95-6 | Slutten av sekvensen | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤ 1,0% |
| 20 | BOC-MET-OH | 2488-15-5 | Slutten av sekvensen | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤ 1,0% |
| 21 | BOC-TYR (TBU) -OH | 47375-34-8 | Slutten av sekvensen | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤ 1,0% |
| 22 | BOC-D-ARG (PDF) -OH | 187618-60-6 | Slutten av sekvensen | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤ 1,0% |
| 23 | Boc-Asp (Otbu) -OH.Dcha | 1913/12/8 | Slutten av sekvensen | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤ 1,0% |
| 24 | Fmoc-HomoArg (PBF) -OH | 1159680-21-3 | Eptifibatid | ≥98,5% | ≤0,2% | / | ≤0,5% | ≤2,0% |
| 25 | FMOC-ASP-OTBU | 129460-09-9 | Thymalfasin | ≥99,5% | ≤0,1% | ≤0,1% | ≤0,2% | ≤ 1,0% |
| 26 | Fmoc-Tyr (ME) -OH | 77128-72-4 | Carbetocin | ≥98,5% | ≤0,2% | ≤0,3% | ≤0,5% | ≤ 1,0% |
| 27 | Fmoc-orn (BOC) -OH | 109425-55-0 | Atosiban Omnipressin Daptomycin | ≥99,5% | ≤0,1% | ≤0,1% | ≤0,2% | ≤2,0% |
| 28 | Fmoc-d-Tyr (et) -OH | 162502-65-0 | Atosiban | ≥99,5% | ≤0,1% | ≤0,1% | ≤0,2% | ≤ 1,0% |
| 29 | Fmoc-Asp (OALL) -OH | 146982-24-3 | Melanotan | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤ 1,0% |
| 30 | Ac-nle-oh | 15891-49-3 | Melanotan | ≥99,0% | / | ≤0,3% | ≤0,3% | ≤ 1,0% |
| 31 | Fmoc-nle-oh | 77284-32-3 | Melanotan Afamelanotid | ≥99,0% | / | ≤0,3% | ≤0,3% | ≤ 1,0% |
| 32 | Ac-Glu (Otbu) -OH | 84192-88-1 | Argireline Acetyl oktapeptid-3 | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤ 1,0% |
| 33 | AC-ß-Ala-OH · DCHA | / | Acetyltrapeptid-5 | ≥99,0% | / | ≤0,3% | ≤0,3% | ≤ 1,0% |
| 34 | Fmoc-ß-ala-oh | 35737-10-1 | Acetyltrapeptid-5 | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤ 1,0% |
| 35 | Fmoc-hyp (TBU) -OH | 122996-47-8 | Icatibant | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤ 1,0% |
| 36 | Fmoc-tii-oh | 130309-35-2 | Icatibant | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤ 1,0% |
| 37 | Fmoc-d-tic-oh | 130309-33-0 | Icatibant | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤ 1,0% |
| 38 | Fmoc-oic-oh | 130309-37-4 | Icatibant | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤ 1,0% |
| 39 | BOC-SAR-OH | 13734-36-6 | Saralasin | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤ 1,0% |
| 40 | Fmoc-sar-oh | 77128-70-2 | Saralasin | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤ 1,0% |
| 41 | Fmoc-Tyr (SO3NA) -OH.H2O | 106864-37-3 | Sincalide | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤ 1,0% |
| 42 | Fmoc-d-ASP (otbu) -oh | 112883-39-3 | Daptomycin | ≥98,5% | ≤0,2% | ≤0,3% | ≤0,5% | ≤ 1,0% |
| 43 | AC-Ser (TBU) -OH | 77285-09-7 | Afamelanotid | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤ 1,0% |
| 44 | Boc-Homocys (TRT) -OH | 201419-16-1 | Depreotid | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤ 1,0% |
| 45 | Fmoc-Homocys (TRT) -OH | 167015-23-8 | Depreotid | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤ 1,0% |
| 46 | Fmoc-dab-oh | 161420-87-7 | Snake Venom | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤ 1,0% |
*Max1 = maks ukjent renhet
Annen indikator:
- eddiksyre: ≤0,02% (alle produkter)
- Etylacetat: ≤0,5% (alle produkter)
- Alkohol: ≤0,5% (alle produkter)
-MAX UNKJENTE PRECTION: FMOC-TRP (BOC) -OH (143824-78-6) ≤0,3%; Andre ≤0,2%
